Skip to main navigation Skip to search Skip to main content

The effect of multi-strain probiotics on frailty in osteoarthritis patients: a randomized trial focusing on intestinal leak repair

  • Rehman Medical Institute

Research output: Contribution to journal › Article › peer-review

Abstract

Background: Increased intestinal permeability may underlie frailty in osteoarthritis (OA), yet targeted treatments remain limited. This trial evaluates whether multi-strain probiotics can reduce plasma zonulin and improve physical frailty in OA patients. Methods: In a double-blind, 14-week randomized trial, 110 OA patients (aged 45–70) received either daily multi-strain probiotics (Vivomix containing 112 billion CFUs from eight well-characterized strains, n = 54) or placebo (n = 56). Measurements were taken at baseline and again after 14-week duration. The principal statistical endpoint was the variation in plasma zonulin levels, reflecting intestinal permeability, whereas the clinical primary outcome was variation in frailty status using Fried’s criteria. Secondary outcome measurements were pain intensity, Oxford Knee Score, handgrip strength (HGS), gait speed, knee range of motion (ROM), inflammatory and oxidative stress biomarkers (hsCRP, 8-isoprostanes), and safety. Results: Following participant dropout, 103 individuals were analysed; placebo (n = 54) and probiotic (n = 49). Multi-strain probiotic supplementation significantly reduced frailty scores, plasma zonulin, walking-related pain, and disease severity, and improved HGS and gait speed (p < 0.05). No considerable alterations were detected in ROM, pain at rest, or levels of 8-isoprostanes. Correlation analysis showed a stronger association between frailty and plasma zonulin in the probiotic group after 14 weeks (r² = 0.273, p < 0.05) than in the placebo group (r² = 0.073, p = 0.048) and baseline (r² = 0.058, p = 0.014). Conclusion: Multi-strain probiotic supplementation reduces frailty in OA patients likely by improving intestinal barrier integrity. Findings are specific to Vivomix® and not broadly applicable to all probiotics. Trial registration: This study was retrospectively registered in Open Science Framework (OSF), registration date (10th August 2025), and URL for protocol (https://osf.io/registries/my-registrations). (Figure presented.)

Original languageEnglish
Pages (from-to)506-514
Number of pages9
JournalEuropean Journal of Clinical Nutrition
Volume80
Issue number5
DOIs
StatePublished - May 2026

Fingerprint

Dive into the research topics of 'The effect of multi-strain probiotics on frailty in osteoarthritis patients: a randomized trial focusing on intestinal leak repair'. Together they form a unique fingerprint.

Cite this